were -lactam-susceptible). PCR assay, sequencing and in silico analysis showed that the CfxA COOH-terminal region (C-ter) in two susceptible isolates was replaced by a glycosyltransferase (96% homology) for one and with a partial hypothetical efflux pump (98% homology) for the other, with 16-bp and 82-bp overlapping gene sequences, respectively. Replacement of the whole C-ter region of cfxA was linked to -lactamase gene inactivation, despite a positive cfxA PCR in the 5' region. Of note, the C-ter region of cfxA appeared to be a preferentially targeted area or 'hotspot' for the acquisition of foreign genetic material.
Among the clinical isolates, 52% harboured plasmids of 3.5, 5 and/or 9 kb. PCR amplified Tn (77.4%), ISCoc1 (61.3%), repA (54.8%) and mobA (74.2%) that was related to plasmid detection (P < 0.05). This was not the case for the oriT gene (16.1%) (P > 0.1) ( Supplementary Table S1 ). In the cfxA-positive Capnocytophaga isolates, mobA and repA genes were mainly detected (100% and 94%, respectively, among plasmid-positive isolates) and related to plasmid detection (P < 0.05). In 74% of mobA-positive isolates, the mobA and cfxA region were linked by a 96-bp intergenic sequence mainly found in plasmid-positive strains (P < 0.01). 
